PRC200-SS (Q7120261)
Jump to navigation
Jump to search
triple reuptake inhibitor investigated by the Mayo Clinic
- PRC200
- (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PRC200-SS |
triple reuptake inhibitor investigated by the Mayo Clinic |
|
Statements
291.162314±0 dalton
1 reference
PRC200 (English)
21 September 2016
C₂₀H₂₁NO
1 reference
PRC200 (English)
21 September 2016
CNCC(C1=CC2=CC=CC=C2C=C1)C(C3=CC=CC=C3)O
1 reference
PRC200 (English)
21 September 2016
CNC[C@H](C1=CC2=CC=CC=C2C=C1)[C@@H](C3=CC=CC=C3)O
1 reference
PRC200 (English)
21 September 2016
Identifiers
1 reference
PRC200 (English)
21 September 2016
1 reference
PRC200 (English)
21 September 2016
1 reference
PRC200 (English)
21 September 2016
2 references
PRC200 (English)
21 September 2016
682-142-9
1 reference
29 July 2019
(1S,2S)-3-(Methylamino)-2-naphthalen-2-yl-1-phenylpropan-1-ol (English)
CAS no.: 492434-58-9 (English)
1 reference
29 July 2019
(1S,2S)-3-(Methylamino)-2-naphthalen-2-yl-1-phenylpropan-1-ol (English)
CAS no.: 492434-58-9 (English)